Cargando…
Non-covalent proteasome inhibitor PI-1840 induces apoptosis and autophagy in osteosarcoma cells
Osteosarcoma (OS) is the predominant form of primary bone malignancy in children and adolescents. Although the combination of chemotherapy and modified surgical therapy leads to marked improvements in the survival rate, the therapeutic outcomes remain unsatisfactory. Therefore, the identification of...
Autores principales: | Chen, Yuxi, Chen, Hongjun, Xie, Hui, Yuan, Shaohui, Gao, Chuanbo, Yu, Lei, Bi, Zhenggang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448088/ https://www.ncbi.nlm.nih.gov/pubmed/30864717 http://dx.doi.org/10.3892/or.2019.7040 |
Ejemplares similares
-
Peiminine Induces G0/G1-Phase Arrest, Apoptosis, and Autophagy via the ROS/JNK Signaling Pathway in Human Osteosarcoma Cells in Vitro and in Vivo
por: Yu, Lei, et al.
Publicado: (2021) -
Proteasome Inhibitors and Their Potential Applicability in Osteosarcoma Treatment
por: Van Stiphout, Cassidy M., et al.
Publicado: (2022) -
Proteasome Inhibitor MG132 Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells and Inhibits Tumor Growth
por: Sun, Farui, et al.
Publicado: (2018) -
Hsp90 inhibitor induces autophagy and apoptosis in osteosarcoma cells
por: MORI, MASAKI, et al.
Publicado: (2014) -
Identification
of Potent and Selective Non-covalent
Inhibitors of the Plasmodium falciparum Proteasome
por: Li, Hao, et al.
Publicado: (2014)